The new member of Hempel A/S Board of Directors Britt Meelby Jensen will aid the company to further strengthen its position in the international coatings market.
The global coatings manufacturer Hempel A/S has recently nominated Britt Meelby Jensen to its Board of Directors, replacing Susanna Schneeberger.
Britt Meelby Jensen, CEO of Ambu A/S, has extensive experience in the life sciences industry, where she has held several leadership roles in global companies for more than two decades. In addition, she holds a master's degree in marketing and international management from Copenhagen Business School (Denmark) and an MBA from Solvay Business School in Brussels (Belgium).
“I am thrilled that Britt Meelby Jensen has accepted to be nominated for the Hempel A/S Board of Directors. With more than 20 years’ experience within healthcare and general management, alongside her contribution to the Hempel Foundation board and the Hempel Invest A/S board, we are convinced that Britt Meelby Jensen is the right profile to join the Hempel A/S Board of Directors. Britt Meelby Jensen brings to Hempel extensive international experience and expertise within leadership of global corporations and she will play an important role in Hempel’s ambitious growth journey. The Hempel Foundation and Hempel Invest A/S have already greatly benefited from her profound business insight and strong leadership and we now look forward to bringing this expertise to the Hempel A/S board,” has commented Richard Sand, Chairman of the Board of Directors of Hempel A/S.